EMEA-002239-PIP01-17

Key facts

Active substance
Rosuvastatin (calcium)/ acetylsalicylic acid
Therapeutic area
Cardiovascular diseases
Decision number
P/0039/2018
PIP number
EMEA-002239-PIP01-17
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Prevention of cardiovascular events
Route(s) of administration
Oral use
Contact for public enquiries
Adamed Sp. z o.o.
Tel. +48227327736
E-mail: joanna.pawlak@adamed.com.pl
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating